Your Strategic Partner in Life Sciences Collaboration
At Oxford Global, we connect solution providers with senior scientists and decision-makers working across drug discovery, development, manufacturing, and commercialisation. From cell and gene therapy to precision medicine, our events and platforms place your brand at the centre of the conversations shaping next-generation therapeutics.
Whether you're targeting niche modalities, therapeutic areas, or end-to-end pipelines, our flexible sponsorship options are designed to boost your visibility and support your sales cycle—so you reach the right partners, and ultimately, patients, faster.
.png?width=560&height=150&name=Biologics%20US%202025%20(Light).png "Biologics US 2025 (Light)")
Proteins & Antibodies
The Proteins & Antibodies programme will explore key topics in engineering and analytical advancements, including;
- Antibody Generation & Protein Design
- Bispecific and Bioconjugation
- AI/ML Tools for Antibody & Protein Engineering
- Computational Epitope Mapping
- Novel In Vitro Display Technologies
ADC Discovery & Development
This year’s ADC Discovery & Development programme explores the critical innovations shaping the next generation of antibody-drug conjugates, including;
- Conjugates & Linker Engineering
- Preclinical Models & Translational Biomarkers
- CMC Strategies & Manufacturing Scalability
- Validation of Novel ADC Targets
- ADCs Beyond Oncology
0 +
Satisfied Customers
0 +
Satisfied Customers
0 +
Satisfied Customers
0 +
Satisfied Customers
0 +
Satisfied Customers
0 +
Satisfied Customers
0 +
Satisfied Customers
0 +
Satisfied Customers
0 +
Satisfied Customers
0 +
Satisfied Customers
0 +
Satisfied Customers
0 +
Satisfied Customers
Biologics 2024 has been one of the best conferences I have attended so far in my career. Good talks, scientists wanting to talk to service/reagent providers, good food and networking events.
The 1:1s are the best thing about Oxford Global events. Biologics 2024 was well organised with a good number of relevant contacts. Good high-level contacts from big companies.
